Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-β-lactamase, in a tertiary care center in Cali, Colombia

Journal of Clinical Microbiology

Volumn 42, Issue 11, 2004, Pages 5094-5101

  Crespo, M P ^a   Woodford, N ^b   Sinclair, A ^b   Kaufmann, M E ^b   Turton, J ^b   Glover, J ^b   Velez, J D ^c   Castaneda C R ^c   Recalde, M ^c   Livermore, D M ^b  

^a UNIVERSIDAD SANTIAGO DE CALI   (Colombia)

^b FUNDACIÓN VALLE DEL LILI   (Colombia)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; BETA LACTAMASE; CARBAPENEM; EDETIC ACID; GENOMIC DNA; IMIPENEM; PROTEIN VIM 8; THREONINE; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SUBSTITUTION; AMPLICON; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COLOMBIA; DISINFECTION; DNA FINGERPRINTING; DNA SEQUENCE; EPIDEMIC; GENETIC POLYMORPHISM; HOSPITAL PATIENT; HYGIENE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE HOMOLOGY; SEROTYPE; STETHOSCOPE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; COLOMBIA; DISEASE OUTBREAKS; HOSPITAL BED CAPACITY, 100 TO 299; HOSPITALS; HUMANS; IMIPENEM; INFANT; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 8644250500     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.11.5094-5101.2004     Document Type: Article

References (36)

1. Andrews, J. M. 2001. Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 48(Suppl. 1):5-16.
2. Andrews, J. M. 2004. BSAC standarized susceptibility routing. Version 3. J. Antimicrob. Chemother. 53:713-728.
3. Chu, G., D. Vollrath, and R. W. Davis. 1986. Separation of large DNA molecules by contour-clamped homogeneous electric fields. Science 234:1582-1585.
4. Cornaglia, G., et al. 1999. Appearance of IMP-1 metallo-β-lactamase in Europe. Lancet 353:899-900.
5. Cornaglia, G., A. Mazzariot, L. Lauretti, G. M. Rossolini, and R. Fontana. 2000. Hospital outbreak of carbapenem resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-β-lactamase. Clin. Infect. Dis. 31:1119-1125.
6. De Freitas, A. L., and A. L. Barth. 2002. Antibiotic resistance and molecular typing of Pseudomonas aeruginosa: focus on imipenem. Braz. J. Infect. Dis. 6:1-7.
7. Gales, A. C., L. C. Menezes, S. Silbert, and H. Sader. 2003. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase. J. Antimicrob. Chemother. 52:699-702.
8. Gales, A. C., R. N. Jones, J. Turnidge, R. Rennie, and R. Ramphal. 2003. Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital. Diagn. Microbiol. Infect. Dis. 45:77-79.
9. Gales, A. C., R. N. Jones, J. Turnidge, R. Rennie, and R. Ramphal. 2001. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance program, 1997-1999. Clin. Infect. Dis. 32:5146-5155.
10. Giamarellou, H. 2002. Prescribing guidelines for severe Pseudomonas infections. J. Antimicrob. Chemother. 49:229-233.
11. IMP-7. Antimicrob. Agents Chemother. 46:255-258.
12. Higgins, P. G., A. C. Fluit, D. Milatovic, J. Verhoef, and F. J. Schmitz. 2002. Antimicrobial susceptibility of imipenem-resistant Pseudomonas aeruginosa. J. Antimicrob. Chemother. 50:299-301.
13. IMP Antimicrob. Agents Chemother. 42:2006-2011.
14. Hirakata, Y., T. Yamaguchi, M. Nakano, K. Izumikawa, M. Mine, S. Aoki, A. Kondoh, J. Matsuda, M. Hirayama, K. Yanagihara, Y. Miyazaki, K. Tomono, Y. Yamada, S. Kamihira, and S. Kohno. 2003. Clinical and bacteriological characteristics of IMP type metallo-β-lactamase producing Pseudomonas. Clin. Infect. Dis. 37:26-32.
15. Howard, D. H., R. D. Scott II, R. Packard, and D. Jones. 2003. The global impact of drug resistance. Clin. Infect. Dis. 36:54-510.
16. Hsueh, P. R., L. J. Teng, P. C. Yang, Y. C. Chen, S. W. Ho, and K. T. Luh. 1998. Persistence of a multidrug-resistant Pseudomonas aeruginosa clone in an intensive care burn unit. J. Clin. Microbiol. 36:1347-1351.
17. Jean, S. S., L. J. Teng, P. R. Hsueh, S. W. Ho, and K. T. Luh. 2002. Antimicrobial susceptibilities among clinical isolates of extended-spectrum cephalosporin-resistant gram-negative bacteria in a Taiwanese university hospital. J. Antimicrob. Chemother. 49:69-76.
18. VIM-2 cassette-containing novel integrons in metallo-β-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital. Antimicrob. Agents Chemother. 46:1053-1058.
19. Livermore, D. M., and N. Woodford. 2000. Carbapenemases: a problem in waiting? Curr. Opin. Microbiol. 3:489-495.
20. Mavroidi, A., A. Tsakris. E. Txelepi, S. Pournaras, V. Loukova, and L. S. Tzouvelekis. 2000. Carbapenem-hydrolysing VIM-2 metallo-β-lactamase in Pseudomonas aeruginosa from Greece. J. Antimicrob. Chemother. 46:1041-1042.
21. Mifsud, A. J., J. Watine, B. Picard, J. C. Charet, C. Solignac- Bourrel, and T. L. Pitt. 1997. Epidemiologically related and unrelated strains of Pseudomonas aeruginosa serotype 012 cannot be distinguished by phenotypic and genotypic typing. J. Hosp. Infect. 36:105-116.
22. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS document M7-A5. National Committee for Clinical Laboratory Standards, Wayne. Pa.
23. Nordmann, P., and L. Poirel. 2002. Emerging carbapenemases in gram-negative aerobes. Clin. Microbiol. Infect. 8:321-331.
24. Pai, H., J. W. Kim, J. Kim, J. H. Lee, K. W. Choe, and N. Gotoh. 2001. Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Antimicrob. Agents Chemother. 45:480-484.
25. Pitt, T. L. 1988. Epidemiological typing of Pseudomonas aeruginosa. Eur. J. Clin. Microbiol. Infect. Dis. 7:238-247.
26. Pitt, T. L., D. M. Livermore, G. Miller, A. Vatopoulos, and N. J. Legakis. 1990. Resistance mechanism of multiresistant serotype O12 Pseudomonas aeruginosa isolated in Europe. J. Antimicrob. Chemother. 26:319-328.
27. VIM-4. J. Antimicrob. Chemother. 51:1409-1414.
28. Rello, J. P., P. Jubert, J. Valles, A. Artigas, M. Rue, and M. S. Niederman. 1996. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin. Infect. Dis. 23:973-978.
29. Senda, K., Y. Arakawa, K. Nakashima, H. Ito, S. Ichiyama, K. Shimokata, N. Kato, and M. Ohta. 1996. Multifocal outbreaks of metallo-β-lactamase- producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems. Antimicrob. Agents Chemother. 40:349-353.
30. IMP-13. harboured by a novel Tn5051-type transposon disseminating carbapenemase genes in Europe: report from the SENTRY worldwide antimicrobial surveillance programme. J. Antimicrob. Chemother. 52:583-590.
31. Toleman, M. A., A. M. Simm, T.A. Murphy, A. C. Gales, K. J. Biedenbach, R. N. Jones, and T. R. Walsh. 2002. Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY Antimicrobial Surveillance programme. J. Antimicrob. Chemother. 50:673-679.
32. Tsakris, A., S. Porunaras, N. Woodford, M. F. Palepou, G. S. Babini, J. Douboyas, and D. M. Livermore. 2000. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J. Clin. Microbiol. 38:1290-1292.
33. Tysall, L., M. W. Stockdale, P. R. Chadwick, M. F. I. Palepou, K. J. Towner, D. M. Livermone, and N. Woodford. 2002. IMP-1 carbapenemase detected in an Acinetobacter clinical isolates from the UK. J. Antimicrob. Chemother. 49:217-218.
34. Woodford, N., M. F. Palepou, G. S. Babini, J. Bates, and D. M. Livermore. 1998. Carbapenemase-producing P. aeruginosa in UK. Lancet 352:546-547.
35. Van, J. J., P. R. Hsueh, W. C. Ko, K. T. Luh, S. H. Tsai, H. M. Wu, and J. J. Wu. 2001. Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob. Agents Chemother. 45:2224-2228.
36. Yong, D., K. Lee, J. H. Yum, H. B. Shin, G. M. Rossolini, and Y. Chong. 2002. Imipenem-EDTA disk method for differentiation of metallo-β-lactamase- producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. Clin. Infect. Dis. 10:3798-3801.